Does Government Involvement Make Pharmaceuticals More or Less Affordable to the End User?

John Zevzavadjian, EVP of Enterprise Platform Solutions, has over 25 years of experience in healthcare and pharmacy management. In his previous role, he served as the SVP of Payer Relations where he led the strategy and execution of all Payer activities at CVS Pharmacy. During the episode, Zevzavadjian discusses the role and challenges of the U.S. government taking on more of the payer. Some of the challenges are the cost of new drugs and the balance around innovation. He says the government has a bias to do something, but he doesn’t see them taking over the total spend. Support the show (https://healthcareamericana.com/sponsors/)